Effects of chronic treatment with vardenafil, a phosphodiesterase 5 inhibitor, on female rat bladder in a partial bladder outlet obstruction model
Authors:
Open Access
- 11 March 2009
- journal article
- Published by Wiley in BJU International
- Vol. 103 (7) , 987-990
Abstract
OBJECTIVES: To investigate whether vardenafil, a phosphodiesterase 5 (PDE‐5) inhibitor, would protect the bladder from decompensatory changes in a 4‐week rat bladder outlet obstruction (BOO) model, as evidence has been accumulating that PDE‐5 inhibitors improve lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: In all, 50 12‐week‐old female Sprague‐Dawley rats were divided into five equal groups; group 1, sham operated vehicle control rats; group 2, BOO vehicle rats; group 3–5, BOO rats given oral vardenafil at 5, 20, 80 mg/L, respectively. Vardenafil was given in drinking water from the day of surgery. At 4‐weeks after the introduction of BOO, vardenafil was washed‐out by giving water for 24–48 h, and then the bladder was excised and dissected into four longitudinal strips for isometric organ‐bath assay. Contractile responses of bladder strips to electrical field stimulation (EFS), carbachol and KCl was determined for each group. RESULTS: BOO induced a significant increase in bladder weight in group 2 compared with group 1. Bladder weights of groups 3–5 were not significantly different from that of group 2. The contractile forces in response to EFS, carbachol and KCl in group 2 were 30.7–51.7% of those in group 1. Vardenafil treatment in groups 3–5 generally did not block the BOO‐induced reduction of contractile force in the bladder strips. However, treatment with a high dose of vardenafil resulted in a significant increase in the contractile response to carbachol (78.4% group 5 vs 51.7% group 2). CONCLUSION: Chronic treatment with a high dose of vardenafil protected the rat bladder from BOO‐induced contractile dysfunction to carbachol.Keywords
This publication has 15 references indexed in Scilit:
- SIGNALING PATHWAYS INVOLVED IN SILDENAFIL-INDUCED RELAXATION OF HUMAN DETRUSORJournal of Urology, 2008
- VARDENAFIL RELAXES PRECONTRACTED RAT DETRUSOR PARTIALLY THROUGH UROTHELIUM-DEPENDENT MECHANISMSEuropean Urology Supplements, 2008
- Effects ofl-arginine andl-NAME on chronic partial bladder outlet obstruction in rabbitAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Vardenafil Improves Urodynamic Parameters in Men With Spinal Cord Injury: Results From a Single Dose, Pilot StudyJournal of Urology, 2007
- Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaJournal of Urology, 2007
- Sildenafil Citrate Improves Erectile Function and Urinary Symptoms in Men With Erectile Dysfunction and Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Randomized, Double-Blind TrialJournal of Urology, 2007
- Role of Nitric Oxide in Urinary Bladder Function: Effect of L-ArginineUrologia Internationalis, 2007
- Pre‐clinical evidence for the use of phosphodiesterase‐5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptomsBJU International, 2006
- Effects of long‐term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's diseaseBJU International, 2006
- Preconditioning protects the guinea‐pig urinary bladder against ischaemic conditions in vitroNeurourology and Urodynamics, 2003